Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003137536 | SCV003821400 | uncertain significance | not provided | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV003989296 | SCV004807684 | uncertain significance | Cryohydrocytosis | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003137536 | SCV005412744 | uncertain significance | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005007882 | SCV005642260 | uncertain significance | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2024-02-10 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000019353 | SCV000039643 | pathogenic | Hereditary spherocytosis type 4 | 2001-06-01 | no assertion criteria provided | literature only |